EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
LuG7g1194bqt4buJNuG7oeG7oeG7tnvhu51Q4buFcOG7iWJ7IUJRfeG6q8OjcH3EqXE2fSIiWz9bW1t94buJ4buF4bq9cX1w4bufZ2rhu4N94bqr4buF4bq7cX1w4bufaH3huqxL4buq4buE4bqoLV01feG6rXU2feG7huG7iTbhu61r4bugxKnhu4Vw4buD4buK4buJ4buFamIuL+G7g10hLuG7nX3huq3hu4k24buh4buh4bu2e+G7neG7gmI24bqpeyFK4buHOOG7r30iNC8zJn3hu4jhu4XDqWp9xKnhu4Vq4buDfeG6reG7g+G6sXF94bqwcX07QlEsfeG6reG7g2t94bqn4buF4bq5cH3huqvDoX3hu4t2fcSpw7VwfXDhu4NvNn1w4buDceG6tWp94bur4buZ4buFfeG6rcOyauG7h31w4buvfeG6qcO54buX4bqtfeG7neG7g8OixKl94buG4buJNuG7rWvhu6DEqeG7hXDhu4Phu4rhu4nhu4VqYn3huq11Nn3hu7Nq4buDfeG7q+G6u33hu6vhu4Xhur3huq194bqtcWrhu4d94bqt4bq34budfeG7icOpan3huqvhurlqfSIiWz9bW1t94buJ4buF4bq9cX1w4bufZ2rhu4N9cOG7g3Hhu43huq194buga3Dhu59r4bur4buFxKk24bqnfeG6q+G7heG6u3F9cOG7n2h94bqn4bq9auG7g31q4buD4bqxan3huqxL4buq4buE4bqoLV01feG6p+G6o2rhu4d94buL4buDN2rhu4d9cOG7g8OqfeG6q+G7k2p94bqpbWrhu4d9xKk4feG7g8OhauG7h31qOOG7r33huqs2auG7h33hu53hu4M3cH1w4buf4buFw6pqP33hu4bhu4k24buta+G7oMSp4buFcOG7g+G7iuG7ieG7hWpifeG6rXNq4buHfWrhu4c44buvfeG6rcO6auG7h33huqvDoX3hu6034bqtfWrhu4PhurVqfXDhu4NvNn1w4buDceG6tWp9ajjhu68/Li/hu50hLuG7nX3huq3hu4k24buh4buh4bu2e+G7neG6pmvhuqnhu697IS7hu4XEqeG7h33huq3hu4k24buh4buh4bu2e+G6rcSp4buhLeG7neG7g2twa3t9cOG7hXDhu4li4bu2e0JRfeG6q8OjcH3EqXE2fSIiWz9bW1t94buJ4buF4bq9cX1w4bufZ2rhu4N94bqr4buF4bq7cX1w4bufaH3huqxL4buq4buE4bqoLV01feG6rXU2feG7huG7iTbhu61r4bugxKnhu4Vw4buD4buK4buJ4buFamJ94buDZ2rhu4N9YWrhu4N9XXt94buh4buf4bqt4bu2ey8v4bqtP+G6qeG7g+G6rWo/4burai/hu4XEqeG7hy/huqli4buh4buLcGvhu50v4bqpLeG6pzZrcOG7gzZq4buD4buDazY/4burai9qYuG7seG7oS8iXSBbL10zM+G6qTBbNDAzMTBwNSIx4buJXT/hu7Fi4bqn4bude3024buJcOG7tntCUX3huqvDo3B9xKlxNn0iIls/W1tbfeG7ieG7heG6vXF9cOG7n2dq4buDfeG6q+G7heG6u3F9cOG7n2h94bqsS+G7quG7hOG6qC1dNX3huq11Nn3hu4bhu4k24buta+G7oMSp4buFcOG7g+G7iuG7ieG7hWpie33huqk2cDYt4bud4buDa3BrLWvhu5/hu4Xhu4fhu4VqNuG7iS3hu6Hhu5/huq3hu7Z74buDcHDhu53hu6ElLy/huq3huqlq4buFxKnhu4c/4bur4buFYnBqNsSp4bud4buJceG7oT/hu6tqL3AyIlsvceG7neG7iWs24bqpYuG6qS/huqdr4buLcHDDrC8iWyJdX1szXyI0L3Bw4but4bural/hu4vhu4M2auG7h19w4buDYl/huq1r4bur4buF4bqpXTU/w6zhu53hu4d7fS8h4buI4buF4bq9cX3hu53hu4M34budfeG6q+G7heG6u3F9cOG7n2h94buL4buDN2rhu4d9cOG7g8OqfeG7oGtw4bufa+G7q+G7hcSpNuG6p33huq3hu4NrfeG6p+G6vWrhu4N9auG7g+G6sWp94bqsS+G7quG7hOG6qC1dNSZ94bqpa33huqzDsmrhu4d9cOG7r33huqnDueG7l+G6rX3hu4bhu4k24buta+G7oMSp4buFcOG7g+G7iuG7ieG7hWpifTvhu7Nq4buDLH3hu6s4feG6rMOyauG7h31w4buvfeG7quG7heG7n33huqbhu4VrcGLhuq3hu4Nqa+G7iWvhu4fhu699O8Sow70sfeG7oWFqfeG7rXHhurdwP307QWrhu4MlfVDhu4NifUo2cOG7hWtqNuG7iS9QUOG7rOG7qkosLi/hu50hLuG7nX3huq3hu4k24buh4buh4bu2e+G7neG6pmvhuqnhu697IVDhu4Nia31CUSZ9cOG7g3Hhu43huq194buga3Dhu59r4bur4buFxKk24bqnJn3huqlrfeG7huG7iTbhu61r4bugxKnhu4Vw4buD4buK4buJ4buFamJ94bud4buD4buN4buFfeG7g+G7l+G7nX3hu6vhu5nhu4V94bqtw7Jq4buHfXDhu6994bqtw7Jq4buHfWrhu4fhu4Phur194buh4buFauG7g33hu4Nu4bqtfeG7quG7heG7n33huqbhu4VrcGLhuq3hu4Nqa+G7iWvhu4fhu6994bqtdTZ9xKjDvX1q4buH4buD4buFw6lqfeG6reG7pXF94burOH3hu53hu4M3cH1w4buf4buFw6pqJn3huq1sfXDhu4PDqn3hu6HGsH3huql0auG7h33huqvDqn3huqvhu4XhurtxfXDhu59ofeG6p+G6vWrhu4N9auG7g+G6sWp94bqsS+G7quG7hOG6qC1dNX3huq1sfXDhu5/hu4Xhur1xfeG6reG7g+G7pWrhu4d9auG7g2QmfeG7i+G7g8OyauG7h33huq3hurNqfXDhu4PGoX1r4but4buvJn1q4buDw7lq4buHfeG6rWx9auG7h3Hhu6994bqt4buTfeG6qeG7heG6v2p94bqn4buF4bq5an3huqfhur1q4buDfWrDo2rhu4d94buD4buTaj8uL+G7nSEu4budfeG6reG7iTbhu6Hhu6Hhu7Z74bud4bqma+G6qeG7r3sh4buC4buF4bq9an3huqzhu5N94bujcTZqfeG7onFhan3hu4l2feG6qcO54buX4bqtfeG7neG7g8OixKl94bqt4buD4bqxcX3hurBxfTtCxKjhu7MsfeG6qzZq4buHfXDhu4XhurlqfeG7gzhq4buDfeG6qzdq4buDfeG7h+G7hTd9cGZq4buDfeG7g+G7heG6vXF94bujcWF94bqtdTZ94buJaznhu4V9cOG7g3Hhu43huq19ajjhu68/Li/hu50hLuG7nX3huq3hu4k24buh4buh4bu2e+G7neG6pmvhuqnhu697IVDhu5/DueG7meG6rX3huqtsJn3EqMO9feG6rcO6auG7h33huqvDoX3huq3hurfhu5194bud4buDY+G7nX3hu6HGsH3huql0auG7h33hu4vhu4PDomp94bqt4bq34budfXDhu4Nx4buN4bqtfeG7oGtw4bufa+G7q+G7hcSpNuG6p33huqvDqn3huqvhu4XhurtxfXDhu59ofeG6p+G6vWrhu4N9auG7g+G6sWp94bqsS+G7quG7hOG6qC1dNX3GoX1w4buDw6p9auG7g2R94bqr4bq5an1w4bufcWrhu4d94bqnZ2rhu4N94burOH3huq1sfWrhu4dx4buvfeG6reG7k33huq3hu4Nx4buvw6pqfeG6p+G7heG6uWp9asOjauG7h33hu4Phu5NqPy4v4budIS7hu5194bqt4buJNuG7oeG7oeG7tnvhu53huqZr4bqp4buveyFQ4buDbzZ9cOG7g3HhurVqfXDhu5/DqWp94bqrw7nhu5fhuq19XTIvIjN94bujceG7jeG6rX3hu4fhu4U2fXDhu4M4auG7g33hu6vhu4XDqWp9QlF9dWrhu4d94buDw7UmfWrhu4Phu6lq4buHfWrDueG7meG6rX3huq3hu4NpfeG6rWx9cOG7g8OqfcSpcTZ9cOG7g3Hhu43huq194buga3Dhu59r4bur4buFxKk24bqnfeG7oTZxfeG7i+G7g+G7hX3huqvDueG7l+G6rX1CxKjhu7N94buDa8Oj4bqtfeG6reG7k33hu6NxNmp94bujcWFqfeG7iXZ94bqpw7nhu5fhuq194bud4buDw6LEqX3hu6Nx4buN4bqtfeG7h+G7hTZ94bqt4buDa33hu53hu4Nj4budfeG7icO5cX3hu4M4auG7gz994buG4buFN31w4bufaH3hu4Phu5fhu5194bqr4buPauG7h33hu4Phu4Xhur1qfeG6reG7g8O5Nn3huqvDueG7l+G6rX1w4buDw7Jq4buHfeG6pzdrPy4v4budIS7hu5194bqt4buJNuG7oeG7oeG7tnvhu53huqZr4bqp4buveyFQ4bufw7nhu5nhuq194bqrbCZ9cOG7gzdq4buHfTB94bur4bunNn3hu6NxNiZ9QlF94bqtw7pq4buHfeG6q8OhfeG7i3Z9xKnDtXB9cOG7g282fXDhu4Nx4bq1an1ww7nhu5Nq4buHfXDFqX3hu6vhu5nhu4V94bqtw7Jq4buHfXDhu6994bqpw7nhu5fhuq194bud4buDw6LEqX3hu55r4bqt4buDYn3huq11Nn1Q4buDdOG7r33hu6DDrX3hu6vhurt94bur4buF4bq94bqtfeG6q8OjcH3EqXE2fTExP1tbW33hu4nhu4XhurtxfXDhu4Nx4buN4bqtfeG6q+G7heG6u3F9cOG7n2h94bqn4bq9auG7g31q4buD4bqxan3huqxL4buq4buE4bqoLV01feG6p+G6o2rhu4d94buL4buDN2rhu4d9cOG7g8OqfeG6q+G7k2p94bqpbWrhu4d9cOG7heG6u8SpfWrDoGrhu4d94bqpa33hu4PDoWrhu4d9ajjhu6994bud4buD4buN4buFfeG7g+G7l+G7nX3hu6vhu5nhu4V94bqtw7Jq4buHfXDhu6994bqpw7nhu5fhuq194bud4buDw6LEqX3hu55i4buHYmpi4bufa2p94bqtdTZ9xKjDvX3hu53hu4M3cH1w4buf4buFw6pqPy4v4budIS7hu5194bqt4buJNuG7oeG7oeG7tnvhu53huqZr4bqp4buveyHhuqrhurlqfWo24buvJn1q4buHazjhu4V94buJ4buF4bq9cX3hu53hu4M34budfeG6q+G7heG6u3F9cOG7n2h94bqn4bqjauG7h33hu4vhu4M3auG7h31w4buDw6p94bqr4buTan3huqltauG7hyZ9QlF94bqt4buDaX3hu6HGsH3huql0auG7h33huqlx4buvfWrhu4PhurdwfcSpw7VwfeG7iWs54buFfXDhu4Nx4buN4bqtfeG6reG7g+G7jWrhu4d94bqsS+G7quG7hOG6qC1dNX3huqvDoX3EqXE2feG7iTh94bueYsSp4bqpYuG7oeG7heG7q+G7heG7n33huq11Nn3hu4PDoWrhu4d94buG4buF4buJYjbhuqkmfcSpw7VwfeG7iWs54buFfXDhu4Nx4buN4bqtfeG7i+G7gzdq4buHfeG7q+G7heG7n3Hhu6E/Li/hu50hLuG7nX3huq3hu4k24buh4buh4bu2e+G7neG6pmvhuqnhu697IUrDoMSpfWrhu4drN+G7hSZ9QlF94bqrw6F94bqrw6NwfcSpcTZ9MVtbP1tbW33hu4nhu4Xhur1xfXDhu59nauG7g31w4buDceG7jeG6rX3hu55ixKnhuqli4buh4buF4bur4buF4buffeG7oTZxfeG7i+G7g+G7hX3huq3hurfhu5194bud4buDY+G7nX3hu6HGsH3huql0auG7h33hu4lrOeG7hX1w4buDceG7jeG6rX1qOOG7rz8vPy4v4budIS7hu5194bqt4buJNuG7oeG7oeG7tnvhu53hu7NxcOG7g2vhu597ITtQUOG7rOG7qkov4buq4buFYnBqNsSpKywuL+G7nSE=
Bình luận
Xin vui lòng gõ tiếng Việt có dấu